AMN Healthcare Services Inc Dossier
|
SectorHealth Care IndustryMedical Care Facilities Beta (adjusted)0.59 Intrinsic Value $49.36median of 5 methods · middle span $32-$64based on filings through 30 Jun 2026 Market Price $35.87Price as of 30 Sep 2026 UndervaluedIntrinsic value is 38% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $1.4B Enterprise Value $1.8B Shares Outstanding 39.7M diluted Moat Rating Wide Next Earnings Date5 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary AMN Healthcare Services Inc. delivered an exceptional Q1 2026 performance, with revenue doubling year-over-year to $1.38 billion and net income turning to a profit of $62.2 million. However, this massive surge was heavily driven by $722 million in episodic, high-margin nurse labor disruption (strike-staffing) revenue. While this windfall allowed AMN to fully repay its revolving credit facility and significantly strengthen its balance sheet, its core segments continue to face structural headwinds. Core technology and physician segments saw year-over-year declines, and the sustainability of traveler volume growth remains unproven once labor disruptions normalize. Given the highly volatile nature of strike-driven revenue and the ongoing post-pandemic normalization of healthcare staffing demand, a Hold recommendation is warranted as the market waits for signs of durable, non-episodic organic growth. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$26.00 Mean target$35.57 High · most bullish analyst$40.00 Street targets sit below today's price; our intrinsic value sits above it. Different horizons, different questions. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $26.00 The bear case materializes if a rapid resolution of labor disputes occurs alongside a steeper-than-expected decline in core travel nurse bill rates. In this scenario, hospital clients aggressively cut costs, leading to a significant drop in MSP spend and VMS utilization. Technology segment revenues continue to contract due to intense competition, and consolidated gross margins compress below 25%. Free cash flow falls short of expectations, causing leverage to rise back toward 3.3x by year-end, leading to multiple contraction and downward analyst revisions. Base CaseCentral scenario $35.57 Matches the consensus meanThe base case assumes that labor disruption revenue normalizes rapidly throughout the remainder of 2026, causing sequential revenue and margin contraction. Core Nurse and Allied traveler volumes show modest, low-single-digit organic stabilization, but are offset by pricing pressures in language services and lower VMS utilization. Net leverage remains manageable around 2.2x to 2.5x, supported by solid free cash flow generation. Valuation multiples remain compressed relative to historical averages as investors demand proof of sustainable, non-episodic earnings power. Bull CaseUpside scenario $40.00 The bull case is predicated on a structural shift in hospital labor management where persistent clinician shortages (with 900,000 nurses expected to leave the workforce by 2027) force healthcare systems into long-term enterprise managed services program (MSP) partnerships. In this scenario, AMN successfully cross-sells its high-margin Smart Square scheduling technology and language services, offsetting any decline in travel nurse bill rates. Furthermore, recurring labor disruptions provide a highly profitable, recurring tactical hedge that consistently boosts free cash flow above $200 million annually, allowing for aggressive debt reduction and opportunistic M&A. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |